04.05.2015 03:55:21
|
John B. Thomas Joins Horizon Pharma
(RTTNews) - John B. Thomas has been appointed executive vice president, strategy and investor relations of Horizon Pharma plc (HZNP), effective immediately.
Previously, Thomas was vice president of investor relations and public affairs for Abbott Laboratories (ABT), where he counseled the senior executive team on the financial community's expectations regarding major acquisitions, divestitures, strategic partnerships, research and development and ongoing business performance.
Prior to joining Abbott, Thomas was manager of corporate communications for Mallinckrodt Veterinary and Budget Rent-A-Car.
At Horizon Pharma, he will be reporting directly to the company's chairman, president and chief executive officer Timothy P. Walbert.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Horizon Therapeutics PLCmehr Nachrichten
Keine Nachrichten verfügbar. |